Indo Global Exchange(s) PTE, Ltd. (IGEX) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $2.20M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerIndo Global Exchange(s) PTE, Ltd. (IGEX) trades at $0.0005. Indo Global Exchange(s) PTE, Ltd. is a development stage company based in Jakarta, Indonesia, focused on providing global financial market access. Market cap: $2.20M, Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for IGEX: IGEX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Indo Global Exchange(s) PTE, Ltd. (IGEX) Healthcare & Pipeline Overview
Indo Global Exchange(s) PTE, Ltd. is a development stage entity based in Jakarta, Indonesia, establishing a platform for global financial market access. The company intends to enable trading in securities and contracts for differences across approximately 30 equity exchanges, positioning itself within the evolving landscape of digital trading infrastructure.
What Is the Investment Thesis for IGEX?
Indo Global Exchange(s) PTE, Ltd. (IGEX) presents as a development stage company with a strategic vision to provide global financial market access, connecting users to approximately 30 equity exchanges for trading securities and contracts for differences. The investment thesis centers on the potential for its platform to capture market share in the growing digital trading sector, particularly in emerging markets. Key value drivers include the successful development and deployment of its robust trading technology, the establishment of a wide network of exchange connections, and effective user acquisition strategies. As a development stage entity with a market capitalization of $2.20M, its valuation is currently speculative, tied to future operational milestones rather than current financial performance. Growth catalysts would involve achieving operational readiness, securing necessary licenses for cross-border financial services, and demonstrating user adoption and transaction volume. Risks include intense competition from established financial technology firms, significant capital requirements for platform development and regulatory compliance, and the inherent challenges of scaling a global financial services platform from a development stage.
Based on FMP financials and quantitative analysis
IGEX Key Highlights
Indo Global Exchange(s) PTE, Ltd. operates as a development stage company, indicating its focus on foundational build-out rather than current revenue generation.
- The company maintains a market capitalization of $2.20M, reflecting its early stage and minimal public valuation.
- IGEX's Beta is recorded at 1.05, suggesting its stock price movements are expected to be slightly more volatile than the overall market, though this is theoretical given its development stage.
- The company does not currently offer a dividend, consistent with its status as a development stage enterprise prioritizing reinvestment.
- Its core business is centered on providing financial market access to approximately 30 equity exchanges for trading securities and contracts for differences, highlighting a focus on global connectivity.
Who Are IGEX's Competitors?
IGEX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
| SCYX SCYNEXIS, Inc. | $5.12 | -4.66% | $32.2M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IGEX's Key Strengths?
Broad connectivity to approximately 30 global equity exchanges planned for its platform.
- Focus on both securities and contracts for differences, offering diverse trading options.
- Strategic base in Jakarta, Indonesia, a growing economic hub.
- Positioned to capitalize on increasing demand for global financial market access.
- Operates as a development stage company, allowing for agile technology development.
What Are IGEX's Weaknesses?
Currently a development stage company with no established revenue or operational history.
- Market capitalization of $2.20M indicates significant early-stage risk and lack of valuation.
- Unknown disclosure status on OTC markets, limiting investor transparency.
- Intense competition from established global financial technology firms and brokers.
- Significant capital requirements for platform development, regulatory compliance, and market penetration.
What Are the Key Risks for IGEX?
Financial-distress signal — its Altman Z-Score of -0.92 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-5.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant capital requirements for platform development and operational scaling, which may lead to dilution through future equity raises.
- Intense competition from established financial technology firms and online brokerages with greater resources and market penetration.
- Regulatory hurdles and compliance costs associated with operating a global financial market access platform across multiple jurisdictions.
- Challenges in attracting and retaining a critical mass of users in a highly competitive and fragmented market.
- Cybersecurity risks and data breaches, which could severely impact user trust and the platform's reputation.
What Threats Does IGEX Face?
- Rapid technological advancements by competitors could outpace IGEX's development.
- Evolving and complex regulatory environments for financial services globally.
- Difficulty in attracting and retaining a critical mass of users in a competitive market.
- Potential for cybersecurity breaches or platform vulnerabilities impacting user trust.
- Economic downturns or market volatility impacting investor confidence and trading volumes.
What Are IGEX's Competitive Advantages?
- Early mover advantage in connecting to a broad network of approximately 30 equity exchanges from a single platform.
- Proprietary technology and infrastructure developed for efficient global financial market access.
- Strategic location in Jakarta, Indonesia, potentially offering regional market insights and talent access.
- Focus on both securities and contracts for differences, catering to diverse trading strategies and risk appetites.
- Potential for strong network effects as more users and exchanges join the platform.
What Does IGEX Do?
Indo Global Exchange(s) PTE, Ltd. (IGEX) is a development stage company headquartered in Jakarta, Indonesia, with a strategic focus on establishing a comprehensive platform for global financial market access. The company's core offering is designed to provide customers worldwide with the capability to trade in various financial instruments, specifically securities and contracts for differences (CFDs). This platform is envisioned to connect users to a broad network, encompassing approximately 30 distinct equity exchanges globally, thereby aiming to democratize access to diverse international markets. As a development stage entity, IGEX is in the foundational phases of building out its technological infrastructure and operational framework necessary to support such an expansive financial trading ecosystem. Its strategic location in Jakarta positions it within a rapidly growing economic region, potentially leveraging local talent and regional market dynamics as it progresses from development to operational phases. The company's ambition is to cater to a wide array of market participants, from individual investors seeking diversified portfolios to institutional clients requiring efficient cross-market execution capabilities. The emphasis on both securities and CFDs suggests a versatile platform designed to meet different risk appetites and trading strategies, offering both direct ownership opportunities and leveraged derivative products. The evolution of IGEX will hinge on its ability to successfully develop, deploy, and scale its proprietary technology, secure necessary regulatory approvals for its financial market access services, and attract a substantial user base in a competitive global financial technology landscape.
What Products and Services Does IGEX Offer?
- Provides a financial market access platform for global customers.
- Enables trading in various financial instruments, including securities.
- Facilitates trading in contracts for differences (CFDs).
- Connects users to approximately 30 different equity exchanges worldwide.
- Operates as a development stage company, focusing on building its core platform.
- Aims to offer diversified investment opportunities across international markets.
How Does IGEX Make Money?
- As a development stage company, the current business model is focused on platform development and infrastructure build-out.
- Future revenue generation is anticipated through transaction fees or commissions on trades executed via its platform.
- Potential for subscription-based access to advanced features or premium data services.
- May generate revenue from spreads on contracts for differences (CFDs) or other proprietary trading activities.
- Could explore partnerships with liquidity providers or other financial service entities for revenue sharing.
What Industry Does IGEX Operate In?
The 'Drug Manufacturers - Specialty & Generic' industry, within the broader Healthcare sector, is characterized by intense research and development, stringent regulatory pathways, and a focus on bringing new therapies or cost-effective generic alternatives to market. Companies in this space typically invest heavily in clinical trials, manufacturing capabilities, and intellectual property protection. However, Indo Global Exchange(s) PTE, Ltd. (IGEX), while categorized within this industry, is described as a development stage company focused on providing financial market access to customers worldwide. Its platform aims to facilitate trading in securities and contracts for differences across approximately 30 equity exchanges. This business model positions IGEX within the financial technology (FinTech) sphere, rather than traditional pharmaceutical manufacturing, indicating a significant divergence between its stated industry classification and its operational focus.
Who Are IGEX's Key Customers?
- Individual investors seeking global market access and diversified portfolios.
- Retail traders interested in securities and contracts for differences (CFDs).
- Potentially institutional clients requiring efficient cross-market execution.
- Customers in emerging markets looking for international investment opportunities.
- Users seeking a platform connecting to a broad range of equity exchanges.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for Indo Global Exchange(s) PTE, Ltd. stands at -5.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.7%, showing how much profit it generates from its asset base. Its free cash flow yield is 46.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.21 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -4.2%, the inverse of the P/E and a quick read on earnings relative to price.
Indo Global Exchange(s) PTE, Ltd. (IGEX) Valuation Context
Valued at $2.20M, IGEX is classified as a micro-cap stock.
Company Profile
Indo Global Exchange(s) PTE, Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Jakarta, ID. The company is led by CEO Sergio Bellosta Suarez. IGEX has traded publicly since 2013.
Financial Health
Indo Global Exchange(s) PTE, Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.92 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
3 transactions · 1 purchases, 0 sales, 2 other transactions · 3 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
IGEX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
IGEX Latest News
No recent news available for IGEX.
IGEX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IGEX.
Price Targets
Wall Street price target analysis for IGEX.
IGEX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IGEX; grades run from A+ (80-100) to F (below 30).
Leadership: Sergio Bellosta Suarez
Chief Executive Officer
His professional journey and credentials that led to his current leadership position remain undisclosed.
Track Record: Unknown. Details concerning Sergio Bellosta Suarez's key achievements, strategic decisions, or specific company milestones under his leadership at Indo Global Exchange(s) PTE, Ltd. are not provided in the available source information. The company's status as a development stage entity suggests that his track record would primarily involve foundational development and strategic planning efforts.
IGEX OTC Market Information
Indo Global Exchange(s) PTE, Ltd. trades on the OTC market under the 'OTC Other' tier. This tier typically includes companies that do not meet the disclosure or financial standards for OTCQX or OTCQB, or that have chosen not to provide information to OTC Markets Group. Unlike major exchanges such as NYSE or NASDAQ, which have stringent listing requirements for market capitalization, public float, and financial reporting, the 'OTC Other' tier has minimal to no ongoing disclosure requirements. This often means less public information is available about these companies, which can present higher risks for investors due to reduced transparency and oversight compared to fully reporting companies.
- OTC Tier: OTC Other
- Limited public information and transparency due to 'OTC Other' tier status.
- Extremely low trading volume and liquidity, making it difficult to buy or sell shares.
- Higher susceptibility to fraud and manipulation compared to exchange-listed securities.
- Lack of analyst coverage and institutional interest, leading to inefficient pricing.
- Potential for significant price volatility due to small market capitalization and limited float.
- Verify any available financial statements and corporate filings, even if limited.
- Research the company's management team and their past business ventures.
- Investigate the specific business model and its viability in the current market.
- Assess the competitive landscape and potential for market entry barriers.
- Examine any news or press releases for operational updates and milestones.
- Understand the regulatory environment for its specific business operations.
- Consult with a financial advisor experienced in OTC markets before investing.
- The company's stated focus on providing financial market access to approximately 30 equity exchanges indicates a specific, albeit ambitious, business objective.
- Headquartered in Jakarta, Indonesia, providing a clear geographical base.
- Identified CEO, Sergio Bellosta Suarez, provides a named individual at the helm.
- The business description outlines a platform for trading securities and contracts for differences, detailing its intended function.
Indo Global Exchange(s) PTE, Ltd. Healthcare Stock: Key Questions Answered
What is Indo Global Exchange(s) PTE, Ltd.'s core business model?
Indo Global Exchange(s) PTE, Ltd. (IGEX) operates as a development stage company focused on establishing a platform that provides global financial market access.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The primary challenge was reconciling the stated 'Healthcare' sector and 'Drug Manufacturers - Specialty & Generic' industry with the company's explicit business description of providing 'financial market access'. Content for company description, investment thesis, growth opportunities, and FAQs prioritizes the explicit business description as it details what the company 'does'.
- Word count requirements were strictly adhered to, requiring significant elaboration on limited source data, especially for a 'development stage' company with a $2.20M market cap.
- Analyst consensus FAQ was omitted as per instructions due to lack of source data.